Scott Huennekens - EndoChoice Holdings Insider

GI -- USA Stock  

USD 8.00  8.00  9,223,372,036,855%

Chairman of the Board
Mr. R. Scott Huennekens is Director of the company. Mr. Huennekens has served as President and Chief Executive Officer of Volcano Corporationrationration a medical imaging company since April 2002. Previously he served as the President and Chief Executive Officer of Digirad Corporationrationration a medical imaging company from 2000 to 2002. He originally joined Digirad as a startup in 1997 as Chief Operating Officer. From 1993 to 1997 he worked at Baxter International Inc. a global health care company with increasing responsibilities including as division Vice President of Sales and Marketing
Age: 50  Chairman Since 2016  MBA    
Huennekens is a member of the board of directors of Volcano Corporationrationrationration, Sonendo, Scripps Translational Science Institute, Transenterix and the Medical Device Manufacturers Association . He received a B.Sc. in Business Administration from the University of Southern California and an MBA from Harvard Business School.

Management Efficiency

The company has Return on Asset (ROA) of (0.47) % which means that for every 100 dollars spent on asset it generated loss of $0.47. This is way below average.
The company reports 42.64 M of total liabilities with total debt to equity ratio (D/E) of 0.7 which is normal for its line of buisiness. EndoChoice Holdings has Current Ratio of 5.52 indicating that it is in good position to pay out its debt commitments in time.

Similar Executives

Entity Summary

EndoChoice Holdings, Inc., a medical device company, designs and commercializes various solutions for gastrointestinal caregivers in the United States and internationally. EndoChoice Holdings (GI) is traded on New York Stock Exchange in USA. It is located in EndoChoice Holdings, Inc.Alpharetta, GA and employs 501 people.

EndoChoice Holdings Leadership Team

Simon MA, CFO
Scott Huennekens, Chairman, MBA
David Kaufman, Director, MBA
David Mowry, Director
Douglas Ladd, Executive
Rurik Vandevenne, Director
Simon Tam, CEO
John Smyth, Director
James Balkcom, Director
Kevin Rubey, COO, MBA
Mark Gilreath, CEO
Scott Davis, Director
Uri Geiger, Director
Scott Carter, Director
David Gill, CFO
Craig Walker, Director
William Enquist, Director
Michael Ballanger, Director
John Barr, Chairman
Eric Schjelderup, Director

Stock Performance Indicators

Current Sentiment - GI

EndoChoice Holdings Investor Sentiment
Macroaxis portfolio users are indifferent in their judgment towards investing in EndoChoice Holdings. What is your opinion about investing in EndoChoice Holdings? Are you bullish or bearish?
50% Bullish
50% Bearish

Build Optimal Portfolios

Align your risk with return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.